ANIP - ANI Pharmaceuticals Inc Qarzning balans kapitallashuviga nisbati

ANI Pharmaceuticals Inc (ANIP) grafik logotipi

ANI Pharmaceuticals (ANIP) o'z ishlab chiqarishini moddalar sintezining qat'iy ekologik nazoratiga asoslaydi, bunda suv iste'molini minimallashtiradi va kimyoviy moddalarni xavfsiz utilizatsiya qiladi. Brend yuqori sifatli retsept bo'yicha dori vositalari va nishey generiklarining barqaror yetkazib beruvchisi sifatida dorixonalarning ishonchini qozondi. Kamyob dori vositalari assortimentini kengaytirish xarajatlarni optimallashtiradi va joriy ko'rsatkich 0.97 miqdorini tashkil etadi. Ushbu grafik kompaniyaning moliyaviy dinamikasini aks ettiradi.

ANIP (ANI Pharmaceuticals Corp) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 27.10.2026gacha

ANI Pharmaceuticals Inc (ANIP) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi ANI Pharmaceuticals|ANIP - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati ANI Pharmaceuticals Corp|ANIP - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar ANI Pharmaceuticals|ANIP - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati anipharmaceuticals.com|ANIP - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati ANI Pharmaceuticals|ANIP - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati ANI Pharma|ANIP - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati ANI Pharmaceuticals Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:ANIP ANI Pharmaceuticals
ANI Pharma asosiy tovari

Ushbu koeffitsiyent umumiy majburiyatlarning kapitalga nisbatini aks ettirib, moliyaviy leveraj darajasini va kompaniya moliyalashtirish tuzilmasining barqarorligini baholash imkonini beradi. Kitob kapitaliga asoslangan moliyaviy bog'liqlik darajalarini tahlil qilish orqali investor qarz yuklamasi va daromadlilik o'rtasidagi muvozanatni aniqlaydi, bu esa ANI Pharmaceuticals (ANIP) kompaniyasida generik ishlab chiqarishni saqlab qolish va kamyob autoimmun kasalliklarni davolashga mo'ljallangan yuqori marjali dori vositalari segmentini rivojlantirish uchun juda muhimdir.

ANI Pharmaceuticals raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati GLPG (Galapagos N.V.)|MNKD: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati sxtchina.com (SXTC)|Balans kapitallashuviga qarzlar EPRX (Eupraxia Pharmaceuticals Inc.)|BioHarvest Sciences, Inc. - Balans kapitallashuviga qarzlar|Invizyne Technologies, Inc. (EXOZ) - Qarzning balans kapitallashuviga nisbati|ORMP - Qarzning balans qiymatiga nisbati|enterabio.com - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar ipatherapeutics.com|ABVC - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati CPIX|QNTM - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati FibroGen Corporation (FGEN)|Balans kapitallashuviga qarzlar Telomir Pharmaceuticals|Qarzning sof aktivlarga nisbati Rani Therapeutics Holdings RANI|Synergy CHC Corporation - Balans kapitallashuviga qarzlar|RLYB: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati lexariabioscience.com LEXX|PULM (Pulmatrix Corporation) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati PTHL|Qarzning balans qiymatiga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA|Balans kapitallashuviga qarzlar Impact BioMedical, Inc. (IBO)|TNF Pharmaceuticals, Inc. - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati cbdMD Inc. YCBD|PRFX (PainReform Ltd.) - Balans kapitallashuviga qarzlar|Altamira Therapeutics (CYTO) - Balans qiymatiga qarzlar|LIPO: Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar OptiNose Inc|Pieris (PIRS) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Procaps Group Corp|PTPI (Petros Pharmaceuticals) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar qlsyy.net (QLI)|ACELYRIN - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati TFF Pharmaceuticals Inc. TFFP